|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00491348 |
|
Date of registration:
|
23/06/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study
|
|
Scientific title:
|
Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study |
|
Date of first enrolment:
|
April 2007 |
|
Target sample size:
|
23 |
|
Recruitment status: |
Terminated |
|
URL:
|
http://clinicaltrials.gov/show/NCT00491348 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Mei-Chih Tseng, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
NTUH |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- DSM-IV criteria of generalized anxiety disorders with moderate degree
- Participants above 18 years old
Exclusion Criteria:
- Major depression
- Panic disorder
- Obsessive-compulsive disorder
- Post-traumatic disorder
- Eating disorders
- Psychotic disorders; and
- Alcohol or other substance use disorders
- Neurological disease
- Cardio-vascular disease
- Respiratory disease
- Head trauma
Age minimum:
18 Years
Age maximum:
65 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Anxiety
|
|
Worry
|
|
Intervention(s)
|
|
Drug: duloxetine hydrochloride
|
|
Primary Outcome(s)
|
|
difference of brain activation on worry
[Time Frame: two months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|